Menu
A recent New York Times investigation found that part of a COVID-19 relief bill meant to lower drug prices actually increased costs for 340B providers and some of their most vulnerable patients.

NYT Investigation Highlights Federal Law’s Unintended Harm to 340B Providers

Bella Czajkowski, National Correspondent 340B Report Views
A provision in a 2021 COVID-19 relief bill that sought to lower prescription drug prices has actually made some medications [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Four More States Introduce 340B Contract Pharmacy Access Bills in 2025

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in West Virginia, Missouri

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live